Workflow
Qualigen to participate in next funding round for NanoSynex
QLGNQualigen Therapeutics(QLGN) GlobeNewswire·2025-01-28 13:00

Market size expected to reach 4.7billionin2027CARLSBAD,Calif.,Jan.28,2025(GLOBENEWSWIRE)−−QualigenTherapeutics,Inc.(NASDAQ:QLGN)(the“Company”)announcedtodaytheywillbethefirstinvestorsparticipatinginthe2025bridgeroundoffundingforNanoSynex.NanoSynexwillberaisingupto4.7 billion in 2027 CARLSBAD, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”)announced today they will be the first investors participating in the 2025 bridge round of funding for NanoSynex. NanoSynex will be raising up to 500,000. “We are very excited to participate and be the first investors to commit in this round of funding for NanoSynex. The technology they are developing will help the world of Antimicrobial Susceptibi ...